Synchrony Pharmacy
2022 Virtual Educational Symposium

Molecular Diagnosis of Urinary Tract Pathogens

Lori Millner, PhD, NRCC

Wednesday, January 26th | 1:00 pm — 2:00 pm EST

Our Educational Symposium is designed for Administrators, Director of Nursing, and nursing staff that provide care to elderly and developmentally disabled persons. Our desire is to provide networking among leaders in the Post-Acute Care, Long Term Care, and Assisted Living industry while providing education on hot button issues. We hope that participants leave with the knowledge and tools to prepare them for the future.

These presentations provide education on tools to improve the quality of care. The following topic will be
presented: molecular diagnostics and their role in therapy.

Learning Objectives Include:
1. Summarize current molecular methods to detect urinary tract pathogens.
2. Describe what is published regarding correlation of traditional culture methods
versus molecular methods.
3. Describe use of molecular methods in polymicrobial infections.

* Registration and attendance is free.
* This program is approved for Continuing Education for a total of 1 participant hour by NAB/NCERS. Approval Code 20230125-1-A80178-DL.
* This educational offering has been reviewed by Synchrony Pharmacy and is approved for 1.2 contact hours. Synchrony Pharmacy is an approved Kentucky Board of Nursing provider until December 31, 2023. KBN# 7-0019-1221-010.*

Speaker Bios

Lori Millner, PhD, NRCC

Dr. Lori Millner received her PhD in 2011 from the University of Louisville in Pharmacology and Toxicology. Her dissertation focused on the characterization of a phase II metabolic enzyme, N-acetyltranferase, for which she received the K. C. Huang Outstanding Graduate Student of the Year Award and the Dean’s Citation. Following completion of her doctorate, she completed a one year postdoctoral fellowship where she researched Circulating Tumor Cells (CTCs) and cell free nucleic acid (cfNA). In 2012, she entered a 3 year COMACC accredited fellowship in Clinical Chemistry and Toxicology at the University of Louisville Hospital Laboratory. While in the hospital fellowship, Dr. Millner was trained to be a Laboratory Director and responded to over 200 beeper calls and physician inquiries in the University of Louisville Hospital’s high complexity laboratory. During the fellowship, she also continued her research on CTCs and was the lead author on a funded SBIR grant.

Dr. Millner has several peer reviewed and published manuscripts and has won numerous awards for her
research including the Young Investigator Award and Best Abstract Award from the American Association of Clinical Chemists and the Young Scientist Award (Innovator in Science) from the Association of Clinical Scientists. Dr. Millner has served as a consultant for numerous clinical laboratories and has been the director of a high complexity, full service regional reference laboratory (including COVID-19 testing) for the last five years. She has performed several laboratory developed test validations and has experience with many different manufacturers in molecular diagnostic testing

Burden of Hyperkalemia and Lokelma Product Overview

Mara Ward, PharmD

Wednesday, February 23rd | 1:00 pm — 2:00 pm EST

Our Educational Symposium is designed for Administrators, Director of Nursing, and nursing staff that provide care to elderly and developmentally disabled persons. Our desire is to provide networking among leaders in the Post-Acute Care, Long Term Care, and Assisted Living industry while providing education on hot button issues. We hope that participants leave with the knowledge and tools to prepare them for the future.

These presentations provide education on tools to improve the quality of care. The following topic will be
presented: burden and management of hyperkalemia.

Learning Objectives Include:
1. Describe the prevalence, risk factors, signs and symptoms of hyperkalemia.
2. Understand the burden of hyperkalemia, including cost, health care resource utilization, and mortality.
3. List the agents currently available for the treatment of hyperkalemia.
4. Discuss a novel therapy option for the treatment of hyperkalemia, and the differences from other
available treatments.

* Registration and attendance is free.
* This program is NOT associated with continuing education.

Speaker Bios

Mara Ward, PharmD

Mara Ward, PharmD obtained her Bachelor of Science in Pharmacy from The Ohio State University and her Doctor of Pharmacy from the Ohio Northern University. She worked for many years as board certified long term care clinical consultant pharmacist, where she endeavored to improve medication therapy for the frail elderly and developmentally disabled population. She also served as the Consultant Pharmacist Director, Associate Director of Clinical Research, and led the P&T Committee for the pharmacy. During her time at ZS Pharma/Astra Zeneca, Mara has led the new hire training program for the medical affairs renal division and has trained and mentored several new MSLs. She also was on the training team for the Lokelma Speakers Bureau. In 2019 she was promoted to senior medical science liaison. Patient care remains at the center of Mara’s career, and she very much enjoys educating on novel new science and engaging in scientific exchange with thought leaders in the area of nephrology and renal diseases. Mara lives in Dublin, Ohio with her four children and her rescue mutt Teddy.